Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Total invasion of the pancreatic gland by a rare aggressive IPMN: Report of a case.

Makris MC, Koumarelas KC, Mitrousias AS, Karamveri CN, Yettimis EP, Zevlas AN.

Int J Surg Case Rep. 2013;4(10):863-5. doi: 10.1016/j.ijscr.2013.06.009. Epub 2013 Jul 16.

2.

Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.

Sohn TA, Yeo CJ, Cameron JL, Hruban RH, Fukushima N, Campbell KA, Lillemoe KD.

Ann Surg. 2004 Jun;239(6):788-97; discussion 797-9.

3.

Oncocytic-type intraductal papillary mucinous neoplasms: a unique malignant pancreatic tumor with good long-term prognosis.

Marchegiani G, Mino-Kenudson M, Ferrone CR, Warshaw AL, Lillemoe KD, Fernández-del Castillo C.

J Am Coll Surg. 2015 May;220(5):839-44. doi: 10.1016/j.jamcollsurg.2015.01.051. Epub 2015 Feb 11.

PMID:
25840549
4.

MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.

Masuda A, Arisaka Y, Hara S, Matsumoto I, Takenaka M, Sakai A, Shiomi H, Matsuki N, Sugimoto M, Fujita T, Hayakumo T, Ku Y, Ogino S, Azuma T, Kutsumi H.

Pancreatology. 2013 Nov-Dec;13(6):583-8. doi: 10.1016/j.pan.2013.08.007. Epub 2013 Aug 30.

PMID:
24280573
5.

Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas.

Matthaei H, Norris AL, Tsiatis AC, Olino K, Hong SM, dal Molin M, Goggins MG, Canto M, Horton KM, Jackson KD, Capelli P, Zamboni G, Bortesi L, Furukawa T, Egawa S, Ishida M, Ottomo S, Unno M, Motoi F, Wolfgang CL, Edil BH, Cameron JL, Eshleman JR, Schulick RD, Maitra A, Hruban RH.

Ann Surg. 2012 Feb;255(2):326-33. doi: 10.1097/SLA.0b013e3182378a18.

6.

Data analysis of 36 cases with intraductal papillary mucinous neoplasm of the pancreas for their clinicopathological features, diagnosis, and treatment.

Yuan C, Xiu D, Tao M, Ma Z, Jiang B, Li Z, Li L, Wang L, Wang H, Zhang T.

Chin Med J (Engl). 2014;127(23):4087-91.

PMID:
25430454
7.

Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk.

Fritz S, Klauss M, Bergmann F, Strobel O, Schneider L, Werner J, Hackert T, B├╝chler MW.

Ann Surg. 2014 Nov;260(5):848-55; discussion 855-6. doi: 10.1097/SLA.0000000000000980.

PMID:
25379856
8.

Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review.

Tamura K, Ohtsuka T, Ideno N, Aso T, Shindo K, Aishima S, Ohuchida K, Takahata S, Ushijima Y, Ito T, Oda Y, Mizumoto K, Tanaka M.

Ann Surg. 2014 Feb;259(2):360-8. doi: 10.1097/SLA.0b013e3182a690ff.

PMID:
23989056
9.

Risk of misdiagnosis and overtreatment in patients with main pancreatic duct dilatation and suspected combined/main-duct intraductal papillary mucinous neoplasms.

Crippa S, Pergolini I, Rubini C, Castelli P, Partelli S, Zardini C, Marchesini G, Zamboni G, Falconi M.

Surgery. 2016 Apr;159(4):1041-9. doi: 10.1016/j.surg.2015.11.003. Epub 2015 Dec 17.

PMID:
26704784
10.

Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity.

Sohn TA, Yeo CJ, Cameron JL, Iacobuzio-Donahue CA, Hruban RH, Lillemoe KD.

Ann Surg. 2001 Sep;234(3):313-21; discussion 321-2.

11.

Intraductal papillary mucinous neoplasms of the pancreas: diagnosis and management.

Dongbin L, Fei L, Werner Josefin B, Roland A.

Eur J Gastroenterol Hepatol. 2010 Sep;22(9):1029-38. doi: 10.1097/MEG.0b013e32833b00f9. Review.

PMID:
20520560
12.

Assessment of clonality of multisegmental main duct intraductal papillary mucinous neoplasms of the pancreas based on GNAS mutation analysis.

Tamura K, Ohtsuka T, Matsunaga T, Kimura H, Watanabe Y, Ideno N, Aso T, Miyazaki T, Ohuchida K, Takahata S, Ito T, Ushijima Y, Oda Y, Mizumoto K, Tanaka M.

Surgery. 2015 Feb;157(2):277-84. doi: 10.1016/j.surg.2014.09.013. Epub 2014 Dec 16.

PMID:
25530484
13.

One of the multifocal intraductal papillary mucinous neoplasms with the clinical characteristics of mucinous cystic neoplasm.

Hata T, Sakata N, Motoi F, Unno M.

BMJ Case Rep. 2013 Feb 18;2013. pii: bcr2012008276. doi: 10.1136/bcr-2012-008276.

14.

A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes.

Minagawa N, Sato N, Mori Y, Tamura T, Higure A, Yamaguchi K.

Eur J Surg Oncol. 2013 Jun;39(6):554-8. doi: 10.1016/j.ejso.2013.02.016. Epub 2013 Mar 15.

PMID:
23506840
15.

Inferior head resection of the pancreas for intraductal papillary mucinous neoplasms.

Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N, Kobayashi S, Kojima M, Miyauchi H, Asano T.

J Hepatobiliary Pancreat Sci. 2010 Nov;17(6):798-802. doi: 10.1007/s00534-009-0173-8. Epub 2009 Aug 29.

PMID:
19727540
16.

Extent of surgical resections for intraductal papillary mucinous neoplasms.

Crippa S, Partelli S, Falconi M.

World J Gastrointest Surg. 2010 Oct 27;2(10):347-51. doi: 10.4240/wjgs.v2.i10.347.

17.

Intraductal papillary mucinous neoplasms of the pancreas.

Gourgiotis S, Ridolfini MP, Germanos S.

Eur J Surg Oncol. 2007 Aug;33(6):678-84. Epub 2007 Jan 4. Review.

PMID:
17207960
18.
19.

Recurrence of non-invasive intraductal papillary municious neoplasm seven years following total pancreatectomy.

Dejean NM, Dumitra S, Barkun JS.

Int J Surg Case Rep. 2013;4(9):789-91. doi: 10.1016/j.ijscr.2013.05.009. Epub 2013 May 28.

20.

Multifocal intraductal papillary mucinous neoplasm of the pancreas--a case report.

Chiang KC, Hsu JT, Chen HY, Jwo SC, Hwang TL, Jan YY, Yeh CN.

World J Gastroenterol. 2009 Feb 7;15(5):628-32.

Supplemental Content

Support Center